Document is current
Any future updates will be listed below
-
Authors
Mack, Jasmine A
Voss, Erica A
Rusu, Rada
Hernandez, Meg Celine
Hernandez-Diaz, Sonia
Wyszynski, Diego F
Sylvester, Shirley
DiSantostefano, Rachael L
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 13 April 2022
Accepted: 2 November 2022
First Online: 3 December 2022
Declarations
:
: The Institutional Review Board of the Harvard T.H. Chan School of Public Health approved this study (IRB20-0622). The study was conducted in accordance with ethical principles that have their origin in the Declaration of Helsinki, Guidelines for Good Pharmacoepidemiology Practices, and applicable regulatory requirements. All patients provided written informed consent before participation in the study.
: Not applicable.
: RD and EAV are employees of Janssen Research and Development, LLC and shareholders in Johnson & Johnson stock. SS is an employee and shareholder of Johnson & Johnson. JM, MH, and RR were on temporary contract with Johnson & Johnson at the time of this study and have no conflicts of interest that are relevant to the content of this article. SH and DFW have no conflicts to declare.
